These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 28826188)

  • 1. Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    Basselerie H; Bracoud L; Zeestraten E; Bouguen E; Kiyasova V; Pueyo M; Cognard C; Dumas H; Gramada R; Ousset PJ; Vellas B; Bonneville F
    J Alzheimers Dis; 2017; 60(1):253-262. PubMed ID: 28826188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral microbleeds in early Alzheimer's disease.
    Poliakova T; Levin O; Arablinskiy A; Vasenina E; Zerr I
    J Neurol; 2016 Oct; 263(10):1961-8. PubMed ID: 27389080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of cerebral microbleeds to cognition and incident dementia in non-demented older individuals.
    Paradise M; Seruga A; Crawford JD; Chaganti J; Thalamuthu A; Kochan NA; Brodaty H; Wen W; Sachdev PS
    Brain Imaging Behav; 2019 Jun; 13(3):750-761. PubMed ID: 29802601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment.
    Vasavada MM; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
    J Alzheimers Dis; 2015; 45(3):947-58. PubMed ID: 25633674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid-β Deposition and Long-Term Progression in Mild Cognitive Impairment due to Alzheimer's Disease Defined with Amyloid PET Imaging.
    Hatashita S; Wakebe D
    J Alzheimers Dis; 2017; 57(3):765-773. PubMed ID: 28304292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
    Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
    Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
    Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
    Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple microbleeds are related to cerebral network disruptions in patients with early Alzheimer's disease.
    Heringa SM; Reijmer YD; Leemans A; Koek HL; Kappelle LJ; Biessels GJ;
    J Alzheimers Dis; 2014; 38(1):211-21. PubMed ID: 23948936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K; Dyrba M; Barkhof F; Hausner L; Filippi M; Nestor PJ; Hauenstein K; Klöppel S; Grothe MJ; Kasper E; Teipel SJ
    J Alzheimers Dis; 2015; 48(1):197-204. PubMed ID: 26401940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment.
    Schmand B; Eikelenboom P; van Gool WA;
    J Alzheimers Dis; 2012; 29(3):641-8. PubMed ID: 22297644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral microbleeds are associated with cognitive decline early after ischemic stroke.
    Christ N; Mocke V; Fluri F
    J Neurol; 2019 May; 266(5):1091-1094. PubMed ID: 30761422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of cerebral microbleeds at 7Tesla MRI in patients with early Alzheimer's disease.
    Brundel M; Heringa SM; de Bresser J; Koek HL; Zwanenburg JJ; Jaap Kappelle L; Luijten PR; Biessels GJ
    J Alzheimers Dis; 2012; 31(2):259-63. PubMed ID: 22531417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral microbleeds in patients with mild cognitive impairment and small vessel disease: The Vascular Mild Cognitive Impairment (VMCI)-Tuscany study.
    Valenti R; Del Bene A; Poggesi A; Ginestroni A; Salvadori E; Pracucci G; Ciolli L; Marini S; Nannucci S; Pasi M; Pescini F; Diciotti S; Orlandi G; Cosottini M; Chiti A; Mascalchi M; Bonuccelli U; Inzitari D; Pantoni L;
    J Neurol Sci; 2016 Sep; 368():195-202. PubMed ID: 27538632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    Heinrich J; Vidal JS; Simon A; Rigaud AS; Hanon O; Epelbaum J; Viollet C; Duron E
    J Alzheimers Dis; 2018; 61(3):1133-1141. PubMed ID: 29332036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic Depressive Symptomatology in Mild Cognitive Impairment Is Associated with Frontal Atrophy Rate which Hastens Conversion to Alzheimer Dementia.
    Sacuiu S; Insel PS; Mueller S; Tosun D; Mattsson N; Jack CR; DeCarli C; Petersen R; Aisen PS; Weiner MW; Mackin RS;
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):126-35. PubMed ID: 26238228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral syndromes in mild cognitive impairment and Alzheimer's disease.
    Van der Mussele S; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 38(2):319-29. PubMed ID: 23963290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
    Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
    J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.